Harmony Biosciences Holdings, Inc. HRMY Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $145.62M-8.2% | $158.69M-14.5% | $185.68M+2.6% | $180.9M+18.5% | $152.72M+5.0% | ||
| —— | —— | $26K0.0% | $26K-76.6% | $111K-58.4% | ||
| $43.02M-4.2% | $44.9M-0.2% | $45M-0.2% | $45.07M+0.8% | $44.71M+4.9% | ||
| $341.97M-1.8% | $348.2M+17.0% | $297.61M+14.7% | $259.38M+16.5% | $222.67M+1.3% | ||
| —— | $310K-56.7% | $716K+10.5% | $648K-49.2% | $1.28M+10.7% | ||
| -$225.66M-469% | -$39.65M-35.8% | -$29.2M-19.6% | -$24.41M+59.1% | -$59.68M+12.5% | ||
| $17.5M+7.7% | $16.25M+8.3% | $15M0.0% | $15M0.0% | $15M0.0% | ||
| -$15.92M-75.9% | -$9.05M-3.1% | -$8.78M-26.2% | -$6.95M+9.9% | -$7.71M+29.8% | ||
| $100.4M-66.5% | $299.5M+15.4% | $259.63M+13.5% | $228.75M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.